Abstract
The pyrido[4,3-b]carbazole alkaloids, ellipticine and olivacine, have been attracting considerable interest since many years due to their pronounced antitumour activity. Among the large number of structural variations of these lead compounds which have been performed in search of new agents with enhanced pharmacological profiles, a remarkable proportion of work has been devoted to the synthesis of diazine-fused carbazoles as "aza" analogues (in a broader sense) of the natural products. The present article will give a detailed overview of the literature from the past two decades in this field of medicinal heterocyclic chemistry.
Keywords: N-benzyl-substituted pyridazinone, bromobenzene, antitumour, DNA replication, Diels-Alder approach, intramolecular inverse-electron-demand
Current Organic Chemistry
Title: Diazine Analogues of the Pyridocarbazole Alkaloids
Volume: 10 Issue: 3
Author(s): Norbert Haider
Affiliation:
Keywords: N-benzyl-substituted pyridazinone, bromobenzene, antitumour, DNA replication, Diels-Alder approach, intramolecular inverse-electron-demand
Abstract: The pyrido[4,3-b]carbazole alkaloids, ellipticine and olivacine, have been attracting considerable interest since many years due to their pronounced antitumour activity. Among the large number of structural variations of these lead compounds which have been performed in search of new agents with enhanced pharmacological profiles, a remarkable proportion of work has been devoted to the synthesis of diazine-fused carbazoles as "aza" analogues (in a broader sense) of the natural products. The present article will give a detailed overview of the literature from the past two decades in this field of medicinal heterocyclic chemistry.
Export Options
About this article
Cite this article as:
Haider Norbert, Diazine Analogues of the Pyridocarbazole Alkaloids, Current Organic Chemistry 2006; 10 (3) . https://dx.doi.org/10.2174/138527206775473913
DOI https://dx.doi.org/10.2174/138527206775473913 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Application of DODMA and Derivatives in Cationic Nanocarriers for Gene Delivery
Current Organic Chemistry Chromogranin A and the Endothelial Barrier Function
Current Medicinal Chemistry Cellular Therapy for Ovarian Cancer: Experimental and Clinical Perspectives
Current Medicinal Chemistry AMPK As A Target in Rare Diseases
Current Drug Targets Cell-free DNA: Characteristics, Detection and its Applications in Myocardial Infarction
Current Pharmaceutical Design Alpha9Alpha10 Nicotinic Acetylcholine Receptors as Target for the Treatment of Chronic Pain
Current Pharmaceutical Design Coinage Metal Complexes Against Breast Cancer
Current Medicinal Chemistry Gold Nanoparticles - Synthesis and Applications in Cancer Management
Recent Patents on Materials Science Candida Infections and Human Defensins
Protein & Peptide Letters MicroRNAs in Cancer: Small Molecules, Big Chances
Anti-Cancer Agents in Medicinal Chemistry Multifunctional Radiolabeled Nanoparticles for Targeted Therapy
Current Medicinal Chemistry Radiolabeled Glucose Derivatives for Tumor Imaging Using SPECT and PET
Current Medicinal Chemistry Gene Directed Enzyme Prodrug Therapy for Ovarian Cancer: Could GDEPT Become a Promising Treatment Against Ovarian Cancer?
Anti-Cancer Agents in Medicinal Chemistry Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Current Cardiology Reviews Current and Emerging Therapies in Neuroendocrine Tumors: Impact of Genetic Targets on Clinical Outcomes
Clinical Cancer Drugs Design Strategies, Structures and Molecular Interactions of Small Molecule Src Inhibitors
Anti-Cancer Agents in Medicinal Chemistry The Prognostic and Clinicopathologic Characteristics of OCT4 and Lung Cancer: A Meta-Analysis
Current Molecular Medicine Functional Domains of Aquaporin-1: Keys to Physiology, and Targets for Drug Discovery
Current Pharmaceutical Design Nanoparticles: Functionalization and Multifunctional Applications in Biomedical Sciences
Current Medicinal Chemistry Anticancer Peptides and Proteins: A Panoramic View
Protein & Peptide Letters